These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30252103)

  • 21. Preoperative hydronephrosis as a predictor of postnephroureterectomy survival in patients with upper tract urothelial carcinoma: a two-center study in Japan.
    Fukui T; Kanno T; Kobori G; Moroi S; Yamada H
    Int J Clin Oncol; 2020 Mar; 25(3):456-463. PubMed ID: 31482240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term ureteroscopic management of upper tract urothelial carcinoma: 28-year single-centre experience.
    Maruyama Y; Araki M; Wada K; Yoshinaga K; Mitsui Y; Sadahira T; Nishimura S; Edamura K; Kobayashi Y; Watanabe M; Watanabe T; Monga M; Nasu Y; Kumon H
    Jpn J Clin Oncol; 2021 Jan; 51(1):130-137. PubMed ID: 32715306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.
    Fujita K; Tanigawa G; Imamura R; Nakagawa M; Hayashi T; Kishimoto N; Hosomi M; Yamaguchi S
    Int J Urol; 2013 Jun; 20(6):594-601. PubMed ID: 23131052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Value of
    Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
    Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydronephrosis severity as a predictor of postoperative renal function decline following laparoscopic radical nephroureterectomy.
    Kanno T; Kobori G; Saito R; Ito K; Nakagawa H; Takahashi T; Koterazawa S; Takaoka N; Somiya S; Haitani T; Nagahama K; Ito M; Higashi Y; Moroi S; Akao T; Yamada H
    Int J Clin Oncol; 2024 Apr; 29(4):464-472. PubMed ID: 38316710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDG-PET/CT as a post-treatment restaging tool in urothelial carcinoma: Comparison with contrast-enhanced CT.
    Kitajima K; Yamamoto S; Fukushima K; Yamakado K; Katsuura T; Igarashi Y; Kawanaka Y; Mouri M; Hirota S
    Eur J Radiol; 2016 Mar; 85(3):593-8. PubMed ID: 26860672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma.
    Lee BH; Zabor EC; Tennenbaum D; Furberg H; Benfante N; Coleman JA; Jaimes EA; Russo P
    World J Urol; 2018 Feb; 36(2):257-263. PubMed ID: 29209771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y
    Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma.
    Cheng PY; Lee HY; Li WM; Huang SK; Liu CL; Chen IA; Lin JT; Lo CW; Yu CC; Wang SS; Chen CS; Tseng JS; Lin WR; Yeong-Chin J; Cheong IS; Jiang YH; Lee YK; Chen YT; Chen SH; Chiang BJ; Hsueh TY; Huang CY; Wu CC; Lin WY; Tsai YC; Yu KJ; Huang CP; Huang YY; Tsai CY
    Front Oncol; 2023; 13():944321. PubMed ID: 36910617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management.
    Tanaka H; Yoshida S; Komai Y; Sakai Y; Urakami S; Yuasa T; Yamamoto S; Masuda H; Koizumi M; Kohno A; Fukui I; Yonese J; Fujii Y; Kihara K
    Urol Int; 2016; 96(1):65-72. PubMed ID: 26044598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
    Margulis V; Puligandla M; Trabulsi EJ; Plimack ER; Kessler ER; Matin SF; Godoy G; Alva A; Hahn NM; Carducci MA; Hoffman-Censits J;
    J Urol; 2020 Apr; 203(4):690-698. PubMed ID: 31702432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.
    Brien JC; Shariat SF; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD
    J Urol; 2010 Jul; 184(1):69-73. PubMed ID: 20478585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy.
    Fujita K; Ujike T; Nagahara A; Uemura M; Tanigawa G; Shimazu K; Fushimi H; Yamaguchi S; Nonomura N
    Int J Urol; 2015 May; 22(5):463-7. PubMed ID: 25631522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of estimated glomerular filtration rate and its perioperative change in patients with upper urinary tract urothelial carcinoma: A multi-institutional retrospective study.
    Koguchi D; Matsumoto K; Ikeda M; Taoka Y; Hirayama T; Murakami Y; Utsunomiya T; Matsuda D; Okuno N; Irie A; Iwamura M
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e420-e427. PubMed ID: 29436164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.
    Narukawa T; Hara T; Arai E; Komiyama M; Kawahara T; Kanai Y; Fujimoto H
    Jpn J Clin Oncol; 2015 May; 45(5):488-93. PubMed ID: 25681388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
    Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.